Showing results (131-140 of 247) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|May 23, 2021
Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune DefensesJoseph Sia, Jim Hagekyriakou, Ioana Chindris, et al.
Blood Reviews|July 21, 2023
Do anemia treatments improve quality of life and physical function in patients with myelodysplastic syndromes (MDS)? A systematic reviewAllison Mo, Matthew Poynton, Erica Wood, et al.
Plos One|February 18, 2009
Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitorsElizabeth M Algar, Andrea Muscat, Vinod Dagar, et al.
Radiation Research|June 25, 2014
The curative outcome of radioimmunotherapy in a mouse breast cancer model relies on mTOR signalingInge Verbrugge, Alessia Gasparini, Nicole M Haynes, et al.
The FEBS Journal|January 13, 2016
Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicityVivien R Sutton, Amelia J Brennan, Sarah Ellis, et al.
Blood|February 5, 2011
Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor-induced thrombocytopeniaMark J Bishton, Simon J Harrison, Benjamin P Martin, et al.
Blood|April 23, 2009
The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacyLeigh Ellis, Michael Bots, Ralph K Lindemann, et al.
Plos One|January 30, 2014
Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemiaEdwin D Hawkins, Jane Oliaro, Kelly M Ramsbottom, et al.
Research and Practice in Thrombosis and Haemostasis|September 1, 2020
Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapyHiu Lam Agnes Yuen, Alison Slocombe, Vanessa Heron, et al.
Pathology|April 5, 2024
Day-21 bone marrow findings incorrectly designate residual leukaemia in FLT3-mutated acute myeloid leukaemia treated with intensive induction plus midostaurin: a morphology-focused studyAditya Tedjaseputra, Sukanya Roy, Kay Htun, et al.
Pageof 25